CER Daily Newsfeed

NPC Evaluates ICER’s Revised 2023 Value Assessment Framework: A Missed Opportunity for Patients and the Field

(9/25, National Pharmaceutical Council: E.V.I.dently Today) comments “...Consistent with NPC’s comments, ICER did not lower its threshold range when stating its opinion on the value of treatments. However, ICER continues to threaten to put its thumb on the pricing scale of innovative treatments. Doing so signals a narrowly focused interpretation of a treatment’s value and can do more harm than good to patient access. ICER documented enhanced approaches to patient engagement. However, it remains to be seen whether these efforts will lead to more patient-focused inputs being incorporated into ICER’s analyses and results vs. being another box-checking exercise.” Full

ICER Finalizes Its Approach to Value Assessment. Industry Remains Dissatisfied

(9/26, Brian Reid, Cost Curve) comments “...The topline conclusion is that ICER’s approach, at its core, isn’t going to change that much...Industry had hoped for better. ‘Look, value assessment is not a rule, it is a tool comprised of both science and opinion,’ NPC’s John O’Brien said via email. ‘We're very concerned about the areas that weren't addressed because they have the potential to harm patients and do a disservice to those who've dedicated their lives to the scientific application of value methods.’” Full

Practice Points Developed for Treatment of Outpatient COVID-19

(9/26, HealthDay News) reports “...‘More research evaluating the efficacy, effectiveness, and comparative effectiveness, as well as harms, of pharmacologic and biologic treatments of COVID-19 in the outpatient setting is needed, particularly in the context of changing dominant severe acute respiratory syndrome coronavirus 2 variants and subvariants,’ the authors write.” Full

Advancing Value-Based Care: AMA, AHIP and NAACOS Team up to Launch New Playbook

(9/26, Dan Cook, Benefits Pro) reports “...[A] collaboration of three major organizations has launched a campaign to address the barriers that have so far clipped VBC’s wings. AHIP, the American Medical Association (AMA), and the National Association of ACOs (NAACOS) unveiled their barrier-busting strategy recently with the release of a playbook designed to work VBC adopters over and under the obstacles. The playbook–The Future of Value-Based Care and Payment–went public with the support of a half-hour webinar devoted to the first phase of implementation: data sharing.” Full